New blood tests could slash antibiotic overuse in fragile newborns

NCT ID NCT06058819

Recruiting now Diagnosis Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 25 times

Summary

This study aims to validate new blood markers that can quickly rule out serious infection in newborns, helping doctors avoid giving unnecessary antibiotics. About 358 babies in intensive care with signs of late-onset sepsis will be tested. If successful, these markers could reduce antibiotic resistance and side effects in this vulnerable group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL LATE ONSET SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hôpital Couple-Enfant - CHU Grenoble Alpes
RECRUITING

Grenoble, 38700, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Neonatal intensive care unit, Hôpital femme-maternité
RECRUITING

Nantes, 44300, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
neonatal Intensive care unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, France
RECRUITING

Bron, 69500, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NEONATAL LATE ONSET SEPSIS